Indeed, enumerating the number of incoming and outgoing interactions (corresponding to or from cell-surface receptors, respectively, Fig. 5b) clearly demonstrated that immune signalling within the tumour was dominated by myeloid cells in ME patients and B and T cells in AE patients. The gene discussed is CD177; the disease is neoplasm.